Skip to content
Citation only via OpenAlex

Age related macular degeneration

Usha Chakravarthy, Jennifer R Evans, Philip J. Rosenfeld

BMJ · 2010 · ▲ 93 citations

Abstract

The late stage manifestations of age related macular degeneration, neovascularisation and geographic atrophy, cause severe loss of central vision Standard care for neovascular age related macular degeneration is treatment with monoclonal antibodies that inhibit vascular endothelial growth factor.A fifth of those treated do not respond to treatment and a further quarter may lose the initial gains in visual acuity over time.No proven treatments exist for geographic atrophy.The preventive effects of supplementation with macular carotenoids (lutein/zeaxanthin) and omega3 fatty acids are under investigation.Age related macular degeneration, as the term implies, affects older adults and accounts for about half of all vision impairment or blind

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1136/bmj.c981
Canonical
link ↗
Fetched
2026-10-19 MST

Cite this

APA
Chakravarthy, U., Evans, J.R., &amp; Rosenfeld, P.J. (2010). Age related macular degeneration. <em>BMJ</em>. https://doi.org/10.1136/bmj.c981
Vancouver
Chakravarthy U, Evans JR, Rosenfeld PJ. Age related macular degeneration. BMJ. 2010. doi:10.1136/bmj.c981.
BibTeX
@article{usha2010Agerel, title = {Age related macular degeneration}, author = {Usha Chakravarthy and Jennifer R Evans and Philip J. Rosenfeld}, journal = {BMJ}, year = {2010}, doi = {10.1136/bmj.c981}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings